Brief: Neurosense Regains Compliance With Nasdaq's Minimum Equity Requirement

Neurosense Therapeutics

06/01/2025 14:01

Jan 6 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE REGAINS COMPLIANCE WITH NASDAQ'S MINIMUM EQUITY
REQUIREMENT

Source text:  urn:newsml:reuters.com:*:nPnbzLxcya
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))